Castle Biosciences Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Castle Biosciences Inc. (CSTL) IPO Opens 25% Higher
July 25, 2019 12:19 PM EDTToday's IPO for Castle Biosciences Inc. (NASDAQ: CSTL) opened for trading at $20 after pricing 4,000,000 shares of its common stock at a price to the public of $16.00 per share.
In addition, Castle Biosciences has granted the underwriters a 30-day option to purchase up to... More
